ACE and stroke disorder: Use of medications moderating hypokalemia, such as ACE inhibitors, ARBs, or MRAs, while greater in those with a prior MI or stroke compared with those without prior MI or stroke, was not different in those randomized to CTD compared with HCTZ over the course of the study.